Related Experiment Video
Updated: Jun 26, 2025

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?
Daniel A González-Padilla1, José Daniel Subiela2, Felipe Villacampa-Aubá1
1Department of Urology, Clínica Universidad de Navarra, Madrid, Spain.
Translational Andrology and Urology
|May 9, 2024
Abstract
No abstract available in PubMed .

